Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

BH4 SUPPLEMENTATION AS A NEW TREATMENT FOR DIABETIC CARDIOMYOPATHY

Conference paper

Carnicer R. et al, (2019), HEART, 105, A153 - A153

Protein inhibitor of NOS1 plays a central role in the regulation of myocardial Ca2+ homeostasis in human heart failure

Conference paper

Rosello-Lleti E. et al, (2016), EUROPEAN HEART JOURNAL, 37, 912 - 912

Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Conference paper

Ziberna K. et al, (2016), DIABETOLOGIA, 59, S12 - S12

The role of nitric oxide synthase (NOS) and its essential cofactor tetrahydrobiopterin (BH4) in diabetic cardiomyopathy

Conference paper

Duglan D. et al, (2015), EUROPEAN HEART JOURNAL, 36, 775 - 775

Load More